Innate immune system regulation of retinal regeneration

先天免疫系统对视网膜再生的调节

基本信息

  • 批准号:
    10707048
  • 负责人:
  • 金额:
    $ 44.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Degenerative vision disorders are caused by the loss of retinal cells. In zebrafish, retinal Müller glial (MG) act as stem cells, generating MG-derived progenitor cells (MGPCs) which replace lost retinal cells. Mammalian MG/MGPCs can also produce new retinal neurons, however, proliferative capacity is limited and disease- relevant cell types (e.g., photoreceptors) are rarely generated. Our goal is to understand why the regenerative potential of MG/MGPCs are limited in mammals in comparison to a regenerative species (i.e. zebrafish). In zebrafish, widespread retinal cell loss triggers “developmental” regeneration, producing all major retinal cell classes. Conversely, selective retinal cell loss results in a “fate-biased” process where MGPCs give rise to the lost cell type. How MG sense the extent of loss, however, is unknown. As the immune system plays critical roles during retinal regeneration, we examined the impact of microglia reactivity on MG activation in zebrafish. We observed that microglia are required for MG stem cell activation and that immunosuppression can inhibit or enhance regeneration kinetics depending on the treatment timing. We hypothesize that microglia reactivity levels scale to the extent, duration, and/or specificity of retinal cell loss in order to coordinate MG activation, MGPC proliferation rates and fat decisions to the type of injury incurred. To test our hypothesis, here we propose to combine an improved targeted cell ablation system enabling titratable, sustainable, and selective retinal cell loss with resources/methods for labeling of immune cell types, intravital timelapse imaging, lineage tracing, and single cell transcriptomics. Specifically we will define how the extent (Aim 1), the duration (Aim 2) and specificity (Aim 3) of cone photoreceptor or retinal ganglion cell loss impact immune cell reactivity and retinal regeneration. These experiments will serve to define roles specific immune cell subtypes play in shaping MGPC proliferation and cell fates during regeneration in zebrafish.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY MUMM其他文献

JEFFREY MUMM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY MUMM', 18)}}的其他基金

Innate immune system regulation of retinal regeneration
先天免疫系统对视网膜再生的调节
  • 批准号:
    10444471
  • 财政年份:
    2022
  • 资助金额:
    $ 44.1万
  • 项目类别:
TERM: a novel mutagenesis paradigm enabling streamlined saturation forward genetics in vertebrate models
术语:一种新的诱变范例,可在脊椎动物模型中简化饱和正向遗传学
  • 批准号:
    10477464
  • 财政年份:
    2021
  • 资助金额:
    $ 44.1万
  • 项目类别:
TERM: a novel mutagenesis paradigm enabling streamlined saturation forward genetics in vertebrate models
术语:一种新的诱变范例,可在脊椎动物模型中简化饱和正向遗传学
  • 批准号:
    10288603
  • 财政年份:
    2021
  • 资助金额:
    $ 44.1万
  • 项目类别:
Intersectional transgenic targeting of discrete neuronal and glial subtypes
离散神经元和神经胶质亚型的交叉转基因靶向
  • 批准号:
    10259997
  • 财政年份:
    2021
  • 资助金额:
    $ 44.1万
  • 项目类别:
Improved Animal Models for Cell-Specific Regenerative Medicine Paradigms
细胞特异性再生医学范式的改进动物模型
  • 批准号:
    9104636
  • 财政年份:
    2016
  • 资助金额:
    $ 44.1万
  • 项目类别:
Improved Animal Models for Cell-Specific Regenerative Medicine Paradigms
细胞特异性再生医学范式的改进动物模型
  • 批准号:
    9206193
  • 财政年份:
    2016
  • 资助金额:
    $ 44.1万
  • 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
  • 批准号:
    8771054
  • 财政年份:
    2014
  • 资助金额:
    $ 44.1万
  • 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
  • 批准号:
    8719118
  • 财政年份:
    2014
  • 资助金额:
    $ 44.1万
  • 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
  • 批准号:
    8854178
  • 财政年份:
    2014
  • 资助金额:
    $ 44.1万
  • 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
  • 批准号:
    8913979
  • 财政年份:
    2014
  • 资助金额:
    $ 44.1万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 44.1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了